publication date: Jun. 22, 2018
Norman Coleman, Gay Crawford to receive NCCS Stovall Award for advancing patient-centered care
Norman Coleman, associate director of NCI’s Radiation Research Program and Gay Crawford, founding director of Cancer CAREpoint, were named recipients of the National Coalition for Cancer Survivorship’s Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care.
Named for longtime CEO of NCCS and three-time cancer survivor Ellen Stovall, who died in 2016, the award aims to honor her memory and advocacy by annually recognizing individuals, organizations, or other entities that are innovators in improving cancer care.
Coleman has been affiliated with NCCS since working with Stovall on the NCAB/Senate Subcommittee to Evaluate the National Cancer Program in 1993. He helped form the New England Coalition for Cancer Survivorship while at Harvard. He is senior scientific advisor to the International Cancer Expert Corps, a non-government organization focusing on global disparities in cancer care.
Crawford has counseled thousands of patients and families over the past 44 years. Some of the programs she helped found include: Hospice of the Valley, the second non-profit hospice in California; Courageous Kids, an American Cancer Society program for children with cancer; the California Cancer Registry; the Colon Cancer Free Zone, advocating for colon cancer screening; and was successful in lobbying the insurance industry to pay for breast reconstructions for patients.
In 2011, she was invited to serve as the first chair of Stanford’s new South Bay Cancer Center Patient and Family Advisory Council, helping to develop the program and keep the focus on patient-focused care. In 2013, Crawford founded Cancer CAREpoint, a Silicon Valley based nonprofit organization.
Marc Lippman, breast cancer expert, returns to Georgetown Lombardi
Marc Lippman, a former director of Georgetown Lombardi Comprehensive Cancer Center, is returning as a professor in the departments of oncology and medicine at Georgetown University Medical Center, beginning July 15.
From 1988 to 2001, Lippman served as director of Georgetown Lombardi. During his tenure, he also served as chair of the Department of Oncology, and professor of oncology, medicine and pharmacology at Georgetown University Medical Center. Lippman joins Georgetown Lombardi as a member of the breast cancer program. He will also establish a laboratory and see patients with breast cancer.
Most recently, Lippman served as deputy director of Sylvester Comprehensive Cancer Center at the University of Miami as well as the Kathleen and Stanley Glaser Professor of Medicine at the University of Miami Miller School of Medicine.
Lippman is known for his work in the investigation and treatment of breast cancer. Before coming to Georgetown Lombard in 1988, he led the medical breast cancer section of the medicine branch at NCI, and was senior investigator from 1974 to 1988.
Lippman has been issued multiple patents for his work, including several related to the expression of growth factor receptors in tumor cells. He has published over 400 peer-reviewed articles and is editor-in-chief of Breast Cancer Research and Treatment.
Lippman’s wife, Nanette Bishopric, is a cardiologist and a professor of medicine at the University of Miami Miller School of Medicine, focusing on epigenetic mechanisms underlying heart failure and cancer. She plans to continue working with Lippman on several cancer projects, and will continue her clinical activities at MedStar Washington Hospital Center and MedStar Georgetown University Hospital.
Laura Hutchins named interim director of UAMS Rockefeller Cancer Institute
Laura Hutchins, a hematologist-oncologist at the University of Arkansas for Medical Sciences who specializes in breast cancer, melanoma and brain cancer, has been appointed interim director for the UAMS Winthrop P. Rockefeller Cancer Institute, effective immediately.
She succeeds Peter Emanuel, who recently resigned after leading the institute since 2007. A committee will be formed to conduct a national search for a permanent director.
Hutchins is a professor in the College of Medicine Division of Hematology/Oncology where she was division director from 1998 until September 2013. She also has served as director clinical research at the Cancer Institute since 1998 and has held the Virginia Clinton Kelley Endowed Chair for Clinical Breast Cancer Research since 2007.
She has been a co-investigator on numerous NIH grants including those focused on detection of circulating melanoma cells, and using nanotubes to detect and purge circulating cancer cells.
Her research includes collaborating with Thomas Kieber-Emmons, a fellow scientist to study a UAMS-designed vaccine to prevent the recurrence of breast cancer. That vaccine, now in a phase II clinical trial, is being used in women newly diagnosed with breast cancer to determine if the combination of the vaccine and standard chemotherapy improve the benefit of preoperative therapy.
Hutchins was appointed by the governor to the Arkansas Breast Cancer Research Program Oversight Committee from 2001-2004. From 2004-2012, she was appointed to serve on the state Breast Cancer Control Advisory Board, serving as chairman from 2007-2008.